If you've had one first-degree female relative (sister, mother, daughter) diagnosed with breast cancer, your risk is doubled. If two first-degree relatives have been diagnosed, your risk is 5 times higher than average.
If your brother or father have been diagnosed with breast cancer, your risk is higher, though researchers aren't sure how much higher.
In some cases, a strong family history of breast cancer is linked to having an abnormal gene associated with a high risk of breast cancer, such as the BRCA1 or BRCA2 gene. In other cases, an abnormal CHEK2 gene may play a role in developing breast cancer.
Hormonal therapy medicines: SERMs (selective estrogen receptor modulators) have been shown to reduce the risk of developing hormone-receptor-positive breast cancer in women at high risk. Tamoxifen and Evista (chemical name: raloxifene) are the two SERMs used in this way.
- Tamoxifen has been shown to reduce the risk of first-time hormone-receptor-positive breast cancer in both postmenopausal and premenopausal women at high risk. Certain medicines may interfere with tamoxifen's protective effects. Visit the tamoxifen page to learn more.
- Evista has been shown to reduce the risk of first-time hormone-receptor-positive breast cancer in postmenopausal women. Visit the Evista page to learn more.
Together, you and your doctor can decide if medicine to lower your risk is a good option for you.
More frequent screening: If you're at high risk because of a strong family history of breast cancer, you and your doctor will develop a screening plan tailored to your unique situation. Recommended screening guidelines include:
- a monthly breast self-exam
- a yearly breast exam by your doctor or nurse practitioner
- a mammogram every year starting at age 40
- MRI (magnetic resonance imaging) of the breast
- ultrasound
No comments:
Post a Comment